Insider Transactions in Q4 2022 at Bio Xcel Therapeutics, Inc. (BTAI)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2022
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
30,000
-50.08%
|
$570,000
$19.57 P/Share
|
|
Dec 16
2022
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+42.88%
|
$0
$0.41 P/Share
|
|
Dec 15
2022
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
30,000
-49.52%
|
$600,000
$20.03 P/Share
|
|
Dec 15
2022
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+42.88%
|
$0
$0.41 P/Share
|
|
Nov 11
2022
|
Krishnan Nandabalan Director |
SELL
Open market or private sale
|
Direct |
32,550
-100.0%
|
$488,250
$15.0 P/Share
|
|
Nov 11
2022
|
Krishnan Nandabalan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
32,550
+50.0%
|
$0
$0.41 P/Share
|
|
Nov 10
2022
|
Krishnan Nandabalan Director |
SELL
Open market or private sale
|
Direct |
27,450
-100.0%
|
$411,750
$15.0 P/Share
|
|
Nov 10
2022
|
Krishnan Nandabalan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
27,450
+50.0%
|
$0
$0.41 P/Share
|